Neomycin Sulphate |
|
Appearance: White or yellowish-white powder |
|
CAS:1405-10-3 |
|
Neomycin Sulphate CAS:1405-10-3 Appearance: White or yellowish-white powder Purity: 99% Specification:USP34 encephalopathy, a 0.5 to 1g every 6 hours, the course of 5-6 days. Colon surgery preparation, hourly 0.5g, once every 4 times, followed by every 4 hours, 0.5 g of 24 hours. 2. Pediatric weight on the 1st 25 ~ 50mg/kg, 4 doses. Adverse reactions 1. Can cause loss of appetite, nausea, diarrhea, etc., but does not affect the synthesis of vitamin K long-term use (more than 10 weeks). 2. The less found hearing loss, tinnitus or ear full sense dizziness or gait disturbance urine output significantly reduce the frequency of urination or extreme thirst. 3. Even cause intestinal mucosal atrophy caused by malabsorption syndrome and fatty diarrhea, even pseudomembranous colitis. Taboo disable the product in patients allergic to neomycin or other aminoglycoside antibiotics. ーNote― 1. Cross-allergies an aminoglycoside antibiotics such as streptomycin, gentamicin, amikacin allergic patients may also the allergy. 2. Urine and renal function test still should be conducted regularly in the course of medication to prevent kidney toxicity, and hearing tests, or listening to the determination of the electroretinogram. 3. Following circumstances should be used with caution in the goods: LOCA, the 8th cranial nerve damage, myasthenia gravis, Parkinson's disease, renal dysfunction, ulcerative colitis and oral dental patients (neomycin can cause oral irritation or pain ). 4. Chronic intestinal infections in patients with long-term oral administration of the goods, especially associated with renal dysfunction, or the same service to other ototoxic or nephrotoxic drugs should pay attention to the possibility of renal toxicity or ototoxicity symptoms. Pregnant and lactating women drug― pregnant women should be used with caution in the goods. Medication during breast-feeding women should suspend breast-feeding. Pediatric Use preterm children and newborns lack of security applications the goods, it is not appropriate to the application. Drugs in elderly patients older patients should be used with caution in the product. Drug Interactions 1. The long-term combined oral contraceptives (containing estrogen) may lead to contraceptive failure, and increase the incidence of bleeding. 2. Oral neomycin can affect digitalis glycosides, fluorouracil, methotrexate, penicillin V, vitamin A or vitamin B12 absorption, so that the effect of lowering therefore should be closely observed in patients with the efficacy of the drug digitalis change. Patients with oral neomycin combination of colchicine and vitamin A, vitamin B12 requirement may increase. 3. The product should not be used in combination with other nephrotoxic drugs and ototoxic drugs. 4. Neuromuscular blockade drug combination may increase neuromuscular blockade, resulting in skeletal muscle weakness. Overdosage No specific antagonist of the goods, drug overdose, symptomatic therapy and supportive therapy, such as gastric lavage, emetic and rehydration. Ms. Julia ycgc_int04@yccreate.com
|
|
Neomycin Sulphate CAS:1405-10-3 Appearance: White or yellowish-white powder Purity: 99% Specification:USP34 encephalopathy, a 0.5 to 1g every 6 hours, the course of 5-6 days. Colon surgery preparation, hourly 0.5g, once every 4 times, followed by every 4 hours, 0.5 g of 24 hours. 2. Pediatric weight on the 1st 25 ~ 50mg/kg, 4 doses. Adverse reactions 1. Can cause loss of appetite, nausea, diarrhea, etc., but does not affect the synthesis of vitamin K long-term use (more than 10 weeks). 2. The less found hearing loss, tinnitus or ear full sense dizziness or gait disturbance urine output significantly reduce the frequency of urination or extreme thirst. 3. Even cause intestinal mucosal atrophy caused by malabsorption syndrome and fatty diarrhea, even pseudomembranous colitis. Taboo disable the product in patients allergic to neomycin or other aminoglycoside antibiotics. ーNote― 1. Cross-allergies an aminoglycoside antibiotics such as streptomycin, gentamicin, amikacin allergic patients may also the allergy. 2. Urine and renal function test still should be conducted regularly in the course of medication to prevent kidney toxicity, and hearing tests, or listening to the determination of the electroretinogram. 3. Following circumstances should be used with caution in the goods: LOCA, the 8th cranial nerve damage, myasthenia gravis, Parkinson's disease, renal dysfunction, ulcerative colitis and oral dental patients (neomycin can cause oral irritation or pain ). 4. Chronic intestinal infections in patients with long-term oral administration of the goods, especially associated with renal dysfunction, or the same service to other ototoxic or nephrotoxic drugs should pay attention to the possibility of renal toxicity or ototoxicity symptoms. Pregnant and lactating women drug― pregnant women should be used with caution in the goods. Medication during breast-feeding women should suspend breast-feeding. Pediatric Use preterm children and newborns lack of security applications the goods, it is not appropriate to the application. Drugs in elderly patients older patients should be used with caution in the product. Drug Interactions 1. The long-term combined oral contraceptives (containing estrogen) may lead to contraceptive failure, and increase the incidence of bleeding. 2. Oral neomycin can affect digitalis glycosides, fluorouracil, methotrexate, penicillin V, vitamin A or vitamin B12 absorption, so that the effect of lowering therefore should be closely observed in patients with the efficacy of the drug digitalis change. Patients with oral neomycin combination of colchicine and vitamin A, vitamin B12 requirement may increase. 3. The product should not be used in combination with other nephrotoxic drugs and ototoxic drugs. 4. Neuromuscular blockade drug combination may increase neuromuscular blockade, resulting in skeletal muscle weakness. Overdosage No specific antagonist of the goods, drug overdose, symptomatic therapy and supportive therapy, such as gastric lavage, emetic and rehydration. Ms. Julia ycgc_int04@yccreate.com
|
Industrial field |
additive, pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|